Showing results (41-50 of 83) with videos related to
Sort By:
Pageof 9
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 16, 2009
A novel method of 18F radiolabeling for PETWilliam J McBride, Robert M Sharkey, Habibe Karacay, et al.Nuclear Medicine and Biology|September 2, 2009
In-depth evaluation of the cycloaddition--retro-Diels--Alder reaction for in vivo targeting with [(111)In]-DTPA-RGD conjugatesPeter Laverman, Silvie A Meeuwissen, Sander S van Berkel, et al.EJNMMI Research|June 28, 2015
Therapeutic application of CCK2R-targeting PP-F11: influence of particle range, activity and peptide amountMark W Konijnenberg, Wout A P Breeman, Erik de Blois, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 10, 2012
PET of tumors expressing gastrin-releasing peptide receptor with an 18F-labeled bombesin analogIngrid Dijkgraaf, Gerben M Franssen, William J McBride, et al.Regulatory Peptides|August 26, 2006
A new technique for in vivo imaging of specific GLP-1 binding sites: first results in small rodentsMartin Gotthardt, Georg Lalyko, Julliëtte van Eerd-Vismale, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 5, 2015
Monitoring Therapy Response of Experimental Arthritis with Radiolabeled Tracers Targeting Fibroblasts, Macrophages, or Integrin αvβ3Samantha Y A Terry, Marije I Koenders, Gerben M Franssen, et al.Cancer Biotherapy & Radiopharmaceuticals|May 24, 2013
ImmunoPET imaging of renal cell carcinoma with (124)I- and (89)Zr-labeled anti-CAIX monoclonal antibody cG250 in miceAlexander B Stillebroer, Gerben M Franssen, Peter F A Mulders, et al.Bioconjugate Chemistry|March 23, 2010
Stabilized (111)in-labeled sCCK8 analogues for targeting CCK2-receptor positive tumors: synthesis and evaluationSusan Roosenburg, Peter Laverman, Lieke Joosten, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 22, 2004
Imaging of experimental colitis with a radiolabeled leukotriene B4 antagonistJulliëtte E M van Eerd, Peter Laverman, Wim J G Oyen, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 17, 2011
Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancerSandra Heskamp, Peter Laverman, Daniel Rosik, et al.Pageof 9